Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS studyBarratt, D.; Bandak, B.; Klepstad, P.; Dale, O.; Kaasa, S.; Christrup, L.; Tuke, J.; Somogyi, A.
2006Association between the DRD2 A(1) allele and response to methadone and buprenorphine maintenance treatmentsBarratt, D.; Coller, J.; Somogyi, A.
2018CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantationHu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2012ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsBarratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A.
2014Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaMulholland, C.; Somogyi, A.; Barratt, D.; Coller, J.; Hutchinson, M.; Jacobson, G.; Cursons, R.; Sleigh, J.
2015Pharmacogenetics of opioid responseSomogyi, A.; Coller, J.; Barratt, D.
2008Response to "No influence of ABCB1 haplotypes on methadone dosage requirement"Coller, J.; Barratt, D.; Somogyi, A.
2014Pharmacogenomics of methadone maintenance treatmentSomogyi, A.; Barratt, D.; Ali, R.; Coller, J.